BOLD
Boundless Bio, Inc.
2.46
+0.01 (+0.41%)
52w low 0.9610
3.16 high
68.0% of range
Financial Analysis
| (USD) | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 46.47M | 54.80M | 73.27M | 63.55M | |
| R&D | 37.16M | 42.64M | 55.27M | 44.84M | |
| SG&A | 9.31M | 12.16M | 18.00M | 18.71M | |
| Operating Income | -46.47M | -54.80M | -73.27M | -63.55M | |
| EBITDA | -45.53M | -53.84M | -72.18M | -62.30M | |
| Pretax Income | -45.90M | -49.43M | -65.36M | -58.20M | |
| Net Income | -45.90M | -49.43M | -65.36M | -58.20M | |
| EPS Diluted | -3.28 | -2.22 | -3.85 | -2.60 | |
| Diluted Shares | 13.99M | 22.24M | 16.98M | 22.36M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--